A Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Effect of Symbicort® and Pulmicort® on HAT and HDAC Expression and Activity in Induced Sputum Cells Obtained From COPD Patients.
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 03 Jun 2015 New trial record